The AgAccord
The first of the commercial biotechnology events in the United States will be going “off-patent” and becoming “generic” in 2014. To prepare for the transition, ASTA and the Biotechnology Industry Organization (BIO) worked with the agricultural value chain to create the AgAccord℠. The AgAccord provides a predictable and transparent mechanism to address patent expiration for agricultural biotechnology events.
The AgAccord is now complete and will support a seamless transition to a marketplace that includes both proprietary and off-patent events. Creation of the AgAccord is a proactive milestone for the agricultural biotechnology industry. The number of events coming off-patent in the near future is small and won’t increase significantly until after 2020.
The AgAccord establishes a contractual framework to support business opportunities for those seeking to use off-patent events in the United States while ensuring important global regulatory commitments are maintained for off-patent events so that U.S. exports of products containing these events are not disrupted. The AgAccord comprises two separate agreements that cover the full spectrum of issues related to patent expiration — the Generic Event Marketability and Access Agreement (GEMAA℠) and the Data Use and Compensation Agreement (DUCA). The GEMAA was enacted in November 2012 and has 10 signatories. The DUCA opened for signature in December 2013.
Generic Event Marketability and Access Agreement (GEMAA)
Under the element of the Accord known as the GEMAA, “Proprietary Regulatory Property (PRP) Holders” – those companies that have developed proprietary regulatory information to support the authorizations for events globally — must provide access to the generic event at seed patent expiration. Three years before the last patent on the biotechnology event expires, PRP Holders are required to provide notice of patent expiration. At this point, the PRP Holder has a choice to:
- Independently maintain regulatory responsibility for the event at no cost to users of the generic event
- Seek to share regulatory responsibility; or
- Discontinue regulatory responsibility
Visit www.agaccord.org for more information.

